van Bruggen A C, Dippel D W, Habbema J D, Mooij J J
Department of Neurosurgery, University Hospital Groningen, The Netherlands.
Acta Neurochir (Wien). 1996;138(10):1148-56. doi: 10.1007/BF01809743.
We present a further evaluation of an improved recording method for the acoustic detection of intracranial aneurysms (ADA). A sensor was applied to the patient's eyes. Two measures were derived to summarize the power spectral density function of the sound frequencies that were obtained from each patient: the power median (PM), the median of the power spectral density function, and the mean difference error (MDE), a measure of the difference between the normalized, logarithmically transformed spectra of the patient and a template, the normal spectrum. The capability of these two measures (alone or combined) to discriminate between patients with and without an intracranial aneurysm was tested in a series of 89 patients harbouring a total of 109 aneurysms and 73 controls, using multiple logistic regression analysis. When PM and MDE were combined, the accuracy of the predictions amounted to 79%. Individualized threshold values of the likelihood ratio of harbouring an aneurysm, for ordering four-vessel angiography are suggested, depending on the prior probability of harbouring an aneurysm, the risks of unnecessary angiography and the risk of living with an undetected aneurysm. Our decision analysis suggests that using these recommendations, employing acoustic detection results in a small gain in quality adjusted life expectancy (0.01 life year) for patients aged between 40 and 60, compared to no diagnostic testing, and 0.02 life year compared to angiography, which cannot be recommended. For patients with a three times increased prior risk of harbouring an intracranial aneurysm, the benefit of ADA compared to angiography increases to 0.05 life year. We conclude that acoustic detection has the potential of becoming a useful tool in the non-invasive diagnosis of occult, asymptomatic intracranial aneurysms.
我们对一种改进的用于颅内动脉瘤声学检测(ADA)的记录方法进行了进一步评估。将一个传感器应用于患者眼部。通过两种测量方法来总结从每位患者获得的声音频率的功率谱密度函数:功率中位数(PM),即功率谱密度函数的中位数;以及平均差异误差(MDE),它衡量患者经归一化、对数变换后的频谱与模板(正常频谱)之间的差异。在一系列共89例患有109个动脉瘤的患者和73名对照中,使用多元逻辑回归分析测试了这两种测量方法(单独或联合使用)区分有无颅内动脉瘤患者的能力。当PM和MDE联合使用时,预测准确率达到79%。根据患动脉瘤的先验概率、不必要血管造影的风险以及未检测到动脉瘤而存活的风险,建议了用于安排四血管造影的患动脉瘤似然比的个体化阈值。我们的决策分析表明,与不进行诊断测试相比,对于40至60岁的患者,使用这些建议并采用声学检测可使质量调整预期寿命小幅增加(0.01生命年),与血管造影相比增加0.02生命年,而血管造影是不推荐的。对于患颅内动脉瘤先验风险增加三倍的患者,与血管造影相比,ADA的益处增加到0.05生命年。我们得出结论,声学检测有潜力成为隐匿性、无症状颅内动脉瘤无创诊断的有用工具。